As the U.S. market navigates a landscape marked by tariff tensions and economic uncertainties, major indices like the Dow Jones Industrial Average are experiencing volatility, yet remain poised for potential weekly gains. In this climate of fluctuating investor sentiment and economic indicators, identifying promising small-cap stocks requires a keen eye for companies with strong fundamentals and resilience to macroeconomic pressures.
Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
---|---|---|---|---|
Wilson Bank Holding | NA | 7.87% | 8.22% | ★★★★★★ |
Oakworth Capital | 31.49% | 14.78% | 4.46% | ★★★★★★ |
Cashmere Valley Bank | 15.62% | 5.80% | 3.51% | ★★★★★★ |
Omega Flex | NA | -0.52% | 0.74% | ★★★★★★ |
Solesence | 33.45% | 23.87% | -3.75% | ★★★★★★ |
Anbio Biotechnology | NA | 8.43% | 184.88% | ★★★★★★ |
FRMO | 0.08% | 38.78% | 45.85% | ★★★★★☆ |
Pure Cycle | 5.11% | 1.07% | -4.05% | ★★★★★☆ |
First IC | 38.58% | 9.04% | 14.76% | ★★★★☆☆ |
Reitar Logtech Holdings | 31.39% | 231.46% | 41.38% | ★★★★☆☆ |
Click here to see the full list of 286 stocks from our US Undiscovered Gems With Strong Fundamentals screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Value Rating: ★★★★★★
Overview: IRADIMED CORPORATION specializes in the development, manufacturing, marketing, and distribution of MRI-compatible medical devices and related accessories globally, with a market cap of $658.13 million.
Operations: IRADIMED generates revenue primarily from its patient monitoring equipment segment, which accounts for $73.24 million.
IRADIMED, a nimble player in the medical equipment sector, showcases promising growth potential with its debt-free status over five years and high-quality earnings. Trading at 57.8% below its fair value estimate, the company reported Q4 2024 sales of US$19.39 million, up from US$17.45 million the previous year, and net income of US$5.15 million compared to US$4.54 million a year ago. The firm recently increased its quarterly dividend to $0.17 per share and forecasts annual earnings growth of 12%, though it faces challenges due to reliance on FDA approvals and U.S.-centric revenue streams (85%).
Simply Wall St Value Rating: ★★★★★☆
Overview: Interface, Inc. designs, produces, and sells modular carpet products across various regions including the United States, Canada, Latin America, Europe, Africa, Asia, and Australia with a market capitalization of approximately $1.14 billion.
Operations: Interface generates revenue primarily from its Americas segment, contributing $800.81 million, and the Europe, Africa, Asia, and Australia segment with $514.85 million.
Interface, a notable player in the modular carpet industry, has been making strides with its innovative product launches and strategic initiatives. The company's net debt to equity ratio stands at 41.6%, which is considered high, yet it has successfully reduced this from 163.5% over five years. Interface's earnings grew by an impressive 99.6% last year, outpacing the industry average of 4.6%. Recent product expansions like the Trina Turk X FLOR collection have gained traction in both residential and commercial markets, suggesting strong demand for their unique designs. Despite challenges such as macroeconomic pressures and currency fluctuations, Interface remains focused on sustainability goals and operational efficiency improvements to drive future growth prospects.
Simply Wall St Value Rating: ★★★★★★
Overview: Univest Financial Corporation operates as the bank holding company for Univest Bank and Trust Co., with a market capitalization of $783.34 million.
Operations: The primary revenue streams for Univest Financial come from its banking operations, which generated $249.75 million, followed by wealth management at $29.98 million and insurance services contributing $22.47 million.
Univest Financial, a bank holding company with total assets of US$8.1 billion and equity of US$887.3 million, is trading at 51% below its estimated fair value. The company has a solid foundation with total deposits of US$6.8 billion and loans amounting to US$6.7 billion, backed by an appropriate bad loans ratio of 0.2%. With earnings growth outpacing the industry at 6.8%, Univest also boasts a sufficient allowance for bad loans at 671%. Recent share repurchases indicate confidence in its valuation, while primarily low-risk funding supports stability amidst macroeconomic challenges.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGM:IRMD NasdaqGS:TILE and NasdaqGS:UVSP.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.